Fusion Pharmaceuticals Inc. - Special Call Transcript

Nov 02, 2020 / 01:30PM GMT
Operator

Good morning, and welcome to the Fusion Pharmaceuticals announces collaboration with AstraZeneca conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Amanda Cray, Senior Director of Investor Relations and Corporate Communications. Please go ahead.

Amanda Cray - Fusion Pharmaceuticals Inc. - Senior Director of IR & Corporate Communications

Thank you, Alyssa, and thank you all for joining today's call. This morning, we issued a press release regarding a strategic collaboration with AstraZeneca to discover, develop and commercialize next-generation radiopharmaceuticals and combination therapies. The press release is available on our website at fusionpharma.com.

Joining us on the call today are Chief Executive Officer, John Valliant; Chief Financial Officer, John Crowley; Chief Scientific Officer, Eric Burak; Chief Medical Officer, Jim O'Leary; and Senior Vice President of Business Development, Marc Schwabish. After our prepared remarks, we'll open the call for questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot